One of the fundamental problems with qualitative imaging is the failure to find cancer, or any health problem, when it's present (sensitivity error) or being told you have a health problem, when you don't (specificity error).

​

There are three ways I know when someone is beginning to understand FMTVDM and its paradigm shift in medicine. 

​

First, they quite asking about sensitivity and specificity. They know that's one of the problems with qualitative imaging - not quantitative. 

​

Secondly, they focus on where FMTVDM places them on the health spectrum; not if they do or don't have a disease. 

​

Finally, they ask the question they've been dying to get an answer to. Does their treatment work?

​

Remember one of my fundamental reasons for running a diagnostic test on someone? Will it change what you are doing for the person with the health problem. Nothing is more fundamental than is this treatment working?​

​

Quantitative FMTVDM is defined by accuracy, consistency and reproducibility because it is standardized using the physical constant of the isotope being used. 

​

FMTVDM allows women and men to take a breath and make informed intelligent decisions.

​

That is exactly what the following lady decided to do.

 

In June of 2000, she came in for FMTVDM testing. The result showed tissue in the upper range of normal for her specific FMTVDM test.

 

Six months later she had a second FMTVDM. This time FMTVDM showed InflammoThrombotic Immunologic Response (ITIR) changes in her breast; frequently referred to merely as inflammation.

 

She chose certain non-traditional treatments to reduce the inflammatory changes and returned four months later.

 

This time her third FMTVDM study revealed early Ductal Carcinoma In-situ (DCIS).

​

Having this type of quantitative measurement of her breast health, helped her and her physician make informed treatment decisions without fear.​​​​​

​

​

​

​

​

​

​

​

​

​

​

​

​

​